Mar 27, 2026Tirzepatide and MASH: Can Weight Loss Track Liver Healing?Tirzepatide resolved MASH on biopsy in phase 2 data. Can 10% weight loss, triglycerides, and MRI markers help track liver response?tirzepatidemashliver fibrosisRead article →
Mar 22, 2026Type 2 Diabetes Prevention: Why Knowing Risk Isn’t EnoughType 2 diabetes prevention depends on sustained habits, but new reviews ask whether health literacy can close the gap between risk awareness and action.prediabetestype 2 diabetesblood glucoseRead article →
Mar 22, 2026Artificial Light at Night and Metabolic Risk: What We KnowBedroom and outdoor artificial light at night are linked to obesity, metabolic risk, and depression. Here is what the studies show—and cannot prove.light exposuremetabolic syndromecircadian rhythmRead article →
Mar 18, 2026CGM in Primary Care: Helpful, but Care Structure MattersContinuous glucose monitoring can improve HbA1c in primary care, but short, biased studies leave major questions about durability and support.cgmhba1cglucose controlRead article →
Mar 6, 2026Metabolic Syndrome: What Beats Drugs, and What Adds to ThemA 2026 meta-analysis ranked diet, exercise, and drugs for metabolic syndrome. The surprise result needs context, and GLP-1 plus exercise changes it.metabolic syndromeglp-1 agonistsmetforminRead article →
Feb 28, 2026Semaglutide Protects Kidneys and Reverses Prediabetes in SELECT TrialSELECT secondary analyses: semaglutide cut kidney risk 22%, diabetes progression 78% in non-diabetic obese adults. Real signal, real caveats — full breakdown.semaglutideglp-1 agonistdiabetes preventionRead article →
Feb 24, 2026Flavonoids and Diabetic Bone Loss: Lab Promise vs. RealityResearchers coated bone scaffolds with flavonoids and called it a diabetes bone treatment. It was a petri dish. Here's what the evidence actually says.flavonoidsdiabetesbone regenerationRead article →